Coly PM, Chatterjee S, Mezine F, Jekmek CE, Devue C, Nipoti T, Mazlan S, Corona ML, Dingli F, Loew D, van Niel G, Loyer X, Boulanger CM. Low fluid shear stress stimulates the uptake of noxious endothelial extracellular vesicles via MCAM and PECAM-1 cell adhesion molecules. J Extracell Vesicles. 2024 Oct;13(10):e12414. doi: 10.1002/jev2.12414.
Hulot JS, Janiak P, Boutinaud P, Boutouyrie P, Chézalviel-Guilbert F, Christophe JJ, Cohen A, Damy T, Djadi-Prat J, Firat H, Hervé PY, Isnard R, Jondeau G, Mousseaux E, Pernot M, Prot P, Tyl B, Soulat G, Logeart D; PACIFIC consortium. Rationale and design of the PACIFIC-PRESERVED (PhenomApping, ClassiFication and Innovation for Cardiac dysfunction in patients with heart failure and PRESERVED left ventricular ejection fraction) study. Arch Cardiovasc Dis. 2024 May;117(5):332-342.
Al Sayed ZR, Pereira C, Le Borgne R, Viaris de Lesegno C, Jouve C, Pénard E, Mallet A, Masurkar N, Loussouarn G, Verbavatz JM, Lamaze C, Trégouët DA, Hulot JS. CAVIN-1 mediated hERG dynamics: a novel mechanism underlying the interindividual variability in drug-induced long QT. Circulation. 2024 Apr 29. doi: 10.1161/CIRCULATIONAHA.123.063917. Online ahead of print.
Vermersch E, Neuvendel S, Jouve C, Ruiz-Velasco A, Pereira C, Seguret M, Cattin-Messaoudi ME, Lotfi S, Dorval T, Berson P, Hulot JS. Hsa-miRNA-548v controls the viscoelastic properties of human cardiomyocytes and improve their relaxation rates. JCI Insight. 2024:e161356. doi: 10.1172/jci.insight.161356
Masurkar N, Bouvet M, Logeart D, Claude O, Roux M, Delacroix C, Bergerot D, Mercadier JJ, Sirol M, Gellen B, Livrozet M, Fayol A, Robidel E, Trégouët DA, Marazzi G, Sassoon D, Valente M, Hulot JS. The novel cardiokine GDF3 predicts adverse fibrotic remodeling post-myocardial infarction. Circulation 2023, 147:498-511
Lecoeur E, Domenge O, Fayol A, Jannot AS, Hulot JS. Epidemiology of heart failure in young adults in France. Eur Heart J 2023; 44:383-392
Seguret M, Davidson P, Robben S, Jouve C, Pereira C, Cerveau C, Le Berre M, Rodrigues Ribeiro R, Hulot JS. A versatile high-throughput assay based on 3D ring-shaped cardiac tissues generated from human induced pluripotent stem cell derived cardiomyocytes. Elife. 2024 Apr 5;12:RP87739. doi: 10.7554/eLife.87739
Fayol A, Wack M, Livrozet M, Carves JB, Domengé O, Vermersch E, Mirabel M, Karras A, Le Guen J, Blanchard A, Azizi M, Amar L, Bories MC, Mousseaux E, Carette C, Puymirat E, Hagège A, Jannot AS, Hulot JS. Aetiological classification and prognosis in patients with heart failure with preserved ejection fraction. ESC Heart Fail. 2021 Nov 29. doi: 10.1002/ehf2.13717.
Yaniz-Galende E, Roux M, Nadaud S, Mougenot N, Bouvet M, Claude O, Lebreton G, Blanc C, Pinet F, Atassi F, Perret C, Dierick F, Dussaud S, Leprince P, Tregouet DA, Marazzi G, Sasoon D, Hulot JS. Fibrogenic potential of PW1/Peg3 expressing cardiac stem cells. J Am Coll Cardiol 2017;70:728-741
Hulot JS, Salem JE, Redheuil A, Collet JP, Varnous S, Jourdain P, Logeart D, Gandjbakhch E, Bernard C, Hatem SN, Isnard R, Cluzel P, Le Feuvre C, Leprince P, Hammoudi N, Lemoine F, Klatzman D, Vicaut E, Komajda M, Montalescot G, Lompre AM, Hajjar RJ on behalf of the AGENT-HF investigators. Effect of intracoronary administration of AAV1/SERCA2a on ventricular remodeling in patients with advanced systolic heart failure : Results from the AGENT-HF randomized phase 2 trial. European Journal of Heart Failure 2017 Nov;19(11):1534-1541
Bernard L, Oh JG, Cacheux M, Lee A, Nonnenmacher M, Matasic D, Kohlbrenner E, Kho CW, Pavoine C, Hajjar RJ, Hulot JS. Cardiac Stim1 silencing impairs adaptive hypertrophy and promotes heart failure through inactivation of mTORC2/Akt signaling. Circulation, 2016, 133:1458-71